相关实验视频

Updated: Jun 4, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

对阿尔茨海默病的基于深度学习的诊断算法

Zhenhao Jin¹, Junjie Gong¹, Minghui Deng¹

¹College of Electrical and Information, Northeast Agricultural University, 600 Changjiang Road, Harbin 150038, China.

Journal of imaging

|December 27, 2024

概括

这项研究引入了一种人工智能驱动的两阶段算法,用于使用大脑MRI图像来诊断阿尔茨海默病 (AD). 改进的深度学习模型实现了高精度,有助于早期和高效的AD检测.

科学领域:

神经成像和人工智能的人工智能
医学诊断医学诊断医学诊断

背景情况:

随着人口老龄化,阿尔茨海默病 (AD) 的患病率正在增加.
医学成像和人工智能集成提高了大脑疾病诊断效率.
当前的诊断方法需要提高准确性和速度.

研究的目的:

开发一个创新的二阶段自动辅助诊断算法,用于AD.
提高使用大脑MRI图像诊断阿尔茨海默病的准确性和效率.
为了利用深度学习模型来增强AD检测.

主要方法:

使用了改进的3DDDenseNet细分模型和改进的MobileNetV3分类模型.
修改包括骨干简化,激活/丢失功能的替换,以及3D GAM和CA注意力机制的整合.
扩展卷积和转移学习被用来增强特征提取能力.

主要成果:

拟议的算法实现了高分类准确率:AD/NC的97.85%,MCI/NC的95.31%,AD/MCI的93.96%和AD/MCI/NC的92.63%.
与基线模型相比,准确度的改进在2.6至3.1个百分点之间.
对比和消去研究验证了优越的分类性能.

结论:

开发的基于深度学习的算法为AD提供了准确和高效的自动辅助诊断.
增强的细分和分类模型在检测AD和相关认知障碍方面取得了显著的改进.
这种方法为早期和可靠的阿尔茨海默病诊断提供了有希望的解决方案.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.这就是为什么MRI是MRI.注意力机制注意力机制自动辅助诊断系统自动辅助诊断系统深度学习是一种深度学习.

更多相关视频

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....